nach oben

Journal of Pediatric Neuropsychology

Erschienen in:

01.09.2020 | Review

A Review of Psychological, Social, and Behavioral Functions in the RASopathies

verfasst von: Karin S. Walsh, A. del Castillo, T. Kennedy, A. I. Karim, C. Semerjian

Erschienen in: Journal of Pediatric Neuropsychology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Aims

The aim of this review is to summarize research that has focused on psychological, social, and behavioral functions and outcomes across the RASopathies.

Methods

Empirical studies published in peer-reviewed, scientific journals over the past 32 years were identified through searches in PubMed, PsychInfo, and Google Scholar through July 23, 2019. Searches included the names of each of the RASopathies individually with one psychological search term. The authors reviewed all titles and abstracts for relevancy. Full-text articles of abstracts deemed relevant were then fully reviewed by the authors. Case studies were excluded.

Results

A total of 718 publications were identified through the initial search. Fifty-nine of these publications (8%) were deemed relevant after initial screening and fully reviewed by the authors.

Interpretation

There is a paucity of research on the psychological, social, and behavioral manifestations in children and adults with RASopathies, although an increase in research has emerged over the past 7 years. Dysfunction in these areas can negatively impact the individuals functioning with regard to relationships, education, employment, and quality of life. This review highlights the need for prospective research in these areas of functioning, with the ultimate goal of developing interventions and therapies targeting psychosocial impairments.

Adviento, B., Corbin, I. L., Widjaja, F., Guillaume, D., Enrique, N., Rosser, T., et al. (2014). Autism traits in the RASopathies. Journal of Medical Genetics, 51(1), 10–20.PubMed

Alfieri, P., Piccini, G., Caciolo, C., Perrino, F., Gambardella, M. L., Mallardi, M., et al. (2014). Behavioral profile in RASopathies. American Journal of Medical Genetics Part A, 164(4), 934–942.

Allen, T., Willard, V. W., Anderson, L. M., Hardy, K. K., & Bonner, M. J. (2016). Social functioning and facial expression recognition in children with neurofibromatosis type 1. Journal of Intellectual Disability Research, 60(3), 282–293.PubMed

Axelrad, M. E., Glidden, R., Nicholson, L., & Gripp, K. W. (2004). Adaptive skills, cognitive, and behavioral characteristics of Costello syndrome. American Journal of Medical Genetics Part A, 128A(4), 396–400.PubMed

Axelrad, M. E., Nicholson, L., Stabley, D. L., Sol-Church, K., & Gripp, K. W. (2007). Longitudinal assessment of cognitive characteristics in Costello syndrome. American Journal of Medical Genetics Part A, 143A, 3185–3193.PubMed

Axelrad, M. E., Schwartz, D. D., Fehlis, J., Hopkins, E., Stabley, D. L., Church, K. S., et al. (2009). Longitudinal course of cognitive, adaptive and behavioral characteristics in Costello syndrome. American Journal of Medical Genetics Part A, 149A(12), 2666–2672.PubMedPubMedCentral

Axelrad, M. E., Schwartz, D. D., Katzenstein, J. M., Hopkins, E., & Gripp, K. W. (2011). Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: a review. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 157(2), 115–122.

Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 46(8), 553–563.

Berenguer-Forner, C., Miranda-Casas, A., Pastor-Cerezuela, G., & Roselló-Miranda, R. (2015). Comorbidity of autism spectrum disorder and attention deficit with hyperactivity. A review study. Revista de Neurologia, 50(1), S37–S43 In Spanish.

Cipolletta, S., Spina, G., & Spoto, A. (2017). Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1. Child: Care, Health, and Development, 44(2), 260–268.

Cohen, J. S., Levy, H. P., Sloan, J., Dariotis, J., & Biesecker, B. B. (2015). Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clinical Genetics, 88(5), 425–430.PubMedPubMedCentral

Constantino, J., & Gruber, C. (2005). The Social Responsiveness Scale Manual. Los Angeles: Western Psychological Services.

Costa, R. M., Federov, N. B., Kogan, J. H., Murphy, G. G., Stern, J., Ohno, M., et al. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature, 415, 526–530.PubMed

Coutinho, V., Kemlin, I., Dorison, N., Billette de Villemeur, T., Rodriguez, D., & Dellatolas, G. (2015). Neuropsychological evaluation and parental assessment of behavioral and motor difficulties in children with neurofibromatosis type 1. Research in Developmental Disabilities, 48, 220–230.PubMed

de Sonneville, L. M. J. (1999). Amsterdam neuropsychological tasks: a computer aided assessment programme. In B. P. L. M. Den Brinker, P. J. Beek, A. N. Brand, F. J. Maarse, & L. J. M. Mulder (Eds.), Cognitive ergonomics, clinical assessment and computer assisted learning: computers in psychology (pp. 187–203). Leiden: Swets and Zeitlinger, Lisse.

Denayer, E., Descheemaeker, M.-J., Stewart, D. R., Keymolen, K., Plasschaert, E., Ruppert, S. L., et al. (2011). Observations on intelligence and behavior in 15 patients with Legius syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics, 157(2), 123–128.

Dilts, C. V., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D., Ward, K., Clark, E., & Leonard, C. O. (1996). Children and adolescents with neurofibromatosis 1: a behavioral phenotype. Journal of Developmental & Behavioral Pediatrics, 17(4), 229–239.

Dumas, M. (1998). The risk of social interaction problems among adolescents with ADHD. Education & Treatment of Children, 21(4), 447–460.

Eliason, M. J. (1986). Neurofibromatosis: Implications for learning and behavior. Journal of Developmental & Behavioral Pediatrics, 7(3), 175–179.

Fergusson, D. M., & Woodward, L. J. (2002). Mental health, educational, and social role outcomes of adolescents with depression. Archives of General Psychiatry, 59(3), 225–231.PubMed

Galéra, C., Delrue, M. A., Goizet, C., Etchegoyhen, K., Taupiac, E., Sigaudy, S., et al. (2006). Behavioral and temperamental features of children with Costello syndrome. American Journal of Medical Genetics Part A, 140A(9), 968–974.

Garg, S., Lehtonen, A., Huson, S. M., Emsley, R., Trump, D., Evans, D. G., et al. (2013a). Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Developmental Medicine & Child Neurology, 55(2), 139–145.

Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. G., et al. (2013b). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642–e1648.PubMed

Garg, S., Plasschaert, E., Descheemaeker, M.-J., Huson, S., Borghgraef, M., Vogels, A., et al. (2015). Autism spectrum disorder profile in neurofibromatosis type 1. Journal of Autism & Developmental Disorders, 45(6), 1649–1657.

Garg, S., Heuvelman, H., Huson, S., Tobin, H., Green, J., & Northern UK NF1 Research Network. (2016). Sex bias in autism spectrum disorder in neurofibromatosis type 1. Journal of Neurodevelopmental Disorders, 8(26). https://doi.org/10.1186/s11689-016-9159-4.

Garg, S., Brooks, A., Burns, A., Burkitt-Wright, E., Kerr, B., Huson, S., et al. (2017). Autism spectrum disorder and other neurobehavioral comorbidities in rare disorders of the Ras/MAPK pathway. Developmental Medicine & Child Neurology, 59(5), 544–549.

Garwood, M. M., Bernacki, J. M., Fine, K. M., Hainsworth, K. R., Davis, W. H., & Klein-Tasman, B. P. (2012). Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1. Pain Research and Treatment, 975364. https://doi.org/10.1155/2012/975364

Graf, A., Landolt, M. A., Mori, A. C., & Boltshauser, E. (2006). Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. The Journal of Pediatrics, 149(3), 348–353.PubMed

Gresham, F. M., & Elliot, S. N. (1990). The social skills rating system. Circle Pines: American Guidance Systems, Circle Pines, MN.

Gripp, K. W., & Lin, A. E. (2012). Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genetics in Medicine, 14(3), 285–292.PubMed

Gripp, K., Hopkins, E., Doyle, D., & Dobyns, W. (2010). High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities. American Journal of Medical Genetics, 152A(5), 1161–1168.PubMed

Hopkins, E., Lin, A., Krepkovich, K., Axelrad, M. E., Sol-Church, K., Stabley, D. L., et al. (2010). Living with Costello syndrome: quality of life issues in older individuals. American Journal of Medical Genetics Part A, 152A(1), 84–90.PubMed

Huijbregts, S., & de Sonneville, L. M. J. (2011). Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behavioral Genetics, 41(3), 430–436.

Huijbregts, S., Jahja, R., de Sonneville, L., de Breij, S., & Swaab-Barneveld, H. (2010). Social information processing in children and adolescents with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 52(7), 620–625.

Huijbregts, S. C. J., Loitfelder, M., Rombouts, S. A., Swaab, H., Verbist, B. M., Arkink, E. B., et al. (2015). Cerebral volumetric abnormalities in neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms. Journal of Neurodevelopmental Disorders, 7(32). https://doi.org/10.1186/s11689-015-9128-3.

Jarrett, M. A., & Ollendick, T. H. (2008). A conceptual review of the comorbidity of attention-deficit/hyperactivity disorder and anxiety: Implications for future research and practice. Clinical Psychology Review, 28(7), 1266–1280.PubMed

Johnson, S., & Marlow, N. (2009). Positive screening results on the modified checklist for autism in toddlers: implications for very preterm populations. The Journal of Pediatrics, 154(4), 478–480.PubMed

Johnson, N., Saal, H. M., Lovell, A. M., & Schorry, E. K. (1999). Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. The Journal of Pediatrics, 134(6), 767–772.PubMed

Johnson, H., Wiggs, L., Stores, G., & Huson, S. M. (2005). Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 47(4), 237–242.

Johnson, B., Goldberg-Strassler, D., Gripp, K., Thacker, M., Leoni, C., & Stevenson, D. (2014). Function and disability in children with Costello syndrome and cardiofaciocuaneous syndrome. American Journal of Medical Genetics Part A, 167A, 40–44.PubMed

Kawame, H., Matsui, M., Kurosawa, K., Matsuo, M., Masuno, M., Ohashi, H., et al. (2003). Further delineation of the behavioral and neurologic features in Costello syndrome. American Journal of Medical Genetics Part A, 118A(1), 8–14.PubMed

Kessler, R. C., Petukhova, M., Samson, N. A., Zaslavsky, A. M., & Wittchen, H. U. (2012). Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International Journal of Methods in Psychiatric Research, 21(3), 169–184.PubMedPubMedCentral

Klein-Tasman, B. P., Janke, K. M., Luo, W., Casnar, C. L., Hunter, S. J., Tonsgard, J., et al. (2013). Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. Journal of the International Neuropsychological Society, 20(1), 88–98.PubMedPubMedCentral

Krab, L. C., Goorden, S. M., & Elgersma, Y. (2008). Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. Trends in Genetics, 24(10), 498–510.PubMed

Krab, L. C., Oostenbrink, R., De Goede-Bolder, A., Aarsen, F. K., Elgersma, Y., & Moll, H. A. (2009). Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. The Journal of Pediatrics, 154(3), 420–425.PubMed

Lee, D. A., Portnoy, S., Hill, P., Gillberg, C., & Patton, M. A. (2005). Psychological profile of children with Noonan syndrome. Developmental Medicine & Child Neurology, 47(1), 35–38.

Lewis, A. K., Porter, M. A., Williams, T. A., Bzishvili, S., North, K. N., & Payne, J. M. (2017). Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1. Neuropsychology, 31(4), 361–370.PubMed

Lewis, A. K., Porter, M. A., Williams, T. A., Bzishvili, S., North, K. N., & Payne, J. M. (2018). Attention to faces in social context in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 61(2), 174–180.

Magoulas, P. (2013). RASopathies. Internet page. RASopathiesNet. https://rasopathiesnet.org/rasopathies/.

March, J. S., Parker, J. D., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. Journal of the American Academy of Child. & Adolescent Psychiatry, 36(4), 554–565.

Martin, S., Wolters, P., Baldwin, A., Gillespie, A., Dombi, E., Walker, K., & Widemann, B. (2012). Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables. Journal of Pediatric Psychology, 37(7), 713–724.PubMedPubMedCentral

Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44(3), 164–170.

Mendez, H. M., & Opitz, J. M. (1985). Noonan syndrome: a review. American Journal of Medical Genetics, 21(3), 493–506.PubMed

Morris, S., Acosta, M., Garg, S., Green, J., Huson, S., Legius, E., et al. (2016). Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the international NF1-ASD Consortium Team (INFACT). JAMA Psychiatry, 73(12), 1276–1284.PubMedPubMedCentral

Nacinovich, R., Gadda, S., Maserati, E., Bomba, M., & Neri, F. (2012). Preadolescent anxiety: an epidemiological study concerning an Italian sample of 3,479 nine-year-old pupils. Child Psychiatry & Human Development, 43(1), 27–34.

Noll, R. B., Reiter-Purtill, J., Moore, B. D., Schorry, E. K., Lovell, A. M., Vannatta, K., et al. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics Part A, 143A, 2261–2273.PubMed

Noonan, J. A. (2005). Noonan syndrome. In S. Goldstein & C. R. Reynolds (Eds.), Handbook of neurodevelopmental and genetic disorders in adults (pp. 308–319). New York: Guilford Press.

North, K., Joy, P., Yuile, D., Cocks, N., & Hutchins, P. (1995). Cognitive function and academic performance in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 37(5), 427–436.

North, K., Hyman, S., & Barton, B. (2002). Cognitive deficits in neurofibromatosis 1. Journal of Child Neurology, 17, 605–612.PubMed

Packer, A. (2012). RAS Pathway, a potential unifying theory of autism. Internet page. Spectrum. http://sfari.org/news-and-opinion/directors-columns/2012/ras-pathway-a-potentially-unifying-theory-of-autism.

Pasini, A., Lo-Castro, A., Di Carlo, L., Pitzianti, M., Siracusano, M., Rosa, C., & Galasso, C. (2012). Detecting anxiety symptoms in children and youths with neurofibromatosis type I. American Journal of Medical Genetics Part B, 159B(7), 869–873.

Payne, J. M., Porter, M., Pride, N. A., & North, K. N. (2016). Theory of mind in children with neurofibromatosis type 1. Neuropsychology, 30(4), 439–448.PubMed

Perrino, F., Licchelli, S., Serra, G., Piccini, G., Caciolo, C., Pasqualetti, P., et al. (2017). Psychopathological features in Noonan syndrome. European Journal of Paediatric Neurology, 22(1), 170–177.PubMed

Pierpont, E. I., & Wolford, M. (2016). Behavioral functioning in cardiofaciocutaneous syndrome: risk factors and impact on parenting experience. American Journal of Medical Genetics Part A, 170(8), 1974–1988.PubMed

Pierpont, E., Pierpont, M., Mendelsohn, N., Roberts, A. E., Tworog-Dube, E., Rauen, K. A., et al. (2009). Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome. American Journal of Medical Genetics Part A, 152A(3), 591–600.

Pierpont, E. I., Tworog-Dube, E., & Roberts, A. E. (2015). Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings. Developmental Medicine & Child Neurology, 57, 385–392.

Pierpont, E. I., Hudock, R. L., Foy, A. M., Semrud-Clikeman, M., Pierpont, M. E., Berry, S. A., et al. (2018). Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. Journal of Neurodevelopmental Disorders, 10(21), 1–11.

Pine, D. S., & Klein, R. G. (2008). Anxiety disorders. In M. Rutter, D. Bishop, D. Pine, et al. (Eds.), Rutter’s child and adolescent psychiatry (5th ed., pp. 628–648). London: Blackwell Publishing Ltd..

Plasschaert, E., Descheemaeker, M. J., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2014). Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B, 168(1), 72–80.

Pride, N. A., Crawford, H., Payne, J. M., & North, K. N. (2013). Social functioning in adults with neurofibromatosis type 1. Research in Developmental Disabilities, 34(10), 3393–3399.PubMed

Radloff, L. S. (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.

Rauen, K. A. (2013). The RASopathies. Annual Review of Genomics and Human Genetics, 14, 355–369.PubMedPubMedCentral

Rietman, A. B., Oostenbrink, R., van Noort, K., Franken, M. J. P., Catsman-Berrevoets, C. E., Aarsen, F. K., et al. (2017a). Development of emotional and behavioral problems in neurofibromatosis type 1 during young childhood. American Journal of Medical Genetics Part A, 173(9), 2373–2380.PubMed

Rietman, A. B., van der Vaart, T., Plasschaert, E., Nicholson, B. A., Oostenbrink, R., Krab, L. C., et al. (2017b). Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 177(3), 319–328.

Schwartz, D. D., Katzenstein, J. M., Highley, E. J., Stabley, D. L., Sol-Church, K., Gripp, K. W., & Axelrad, M. E. (2017). Age-related differences in prevalence of autism spectrum disorder symptoms in children and adolescents with Costello syndrome. American Journal of Medical Genetics Part A, 173(5), 1294–1300.PubMedPubMedCentral

Shaw, A., Kalidas, K., Crosby, A., Jeffery, S., & Patton, M. (2007). The natural history of Noonan syndrome: a long-term follow-up study. Archives of Disease in Childhood, 92(2), 128–132.PubMed

Sifneos, P. E. (1973). The prevalence of ‘alexithymic’ characteristics in psychomatic patients. Psychotherapy and Psychosomatics, 22(2), 255–262.PubMed

Smpokou, P., Tworog-Dube, E., Kucherlapati, R. S., & Roberts, A. E. (2012). Medical complications, clinical findings, and educational outcomes in adults with Noonan syndrome. American Journal of Medical Genetics Part A, 158A(12), 3106–3111.PubMed

Tidyman, W. E., & Rauen, K. A. (2009). The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Current Opinions in Genetics and Development, 19(3), 230–236.

van der Burgt, I., Thoonen, G., Roosenboom, N., Assman-Hulsmans, C., Gabreels, F., Otten, B., et al. (1999). Patterns of cognitive functioning in school-aged children with Noonan syndrome associated with variability in phenotypic expression. The Journal of Pediatrics, 135(6), 707–713.PubMed

Verhoeven, W., Wingbermuhle, E., Egger, J., van der Burgt, I., & Tuinier, S. (2007). Noonan syndrome: psychological and psychiatric aspects. American Journal of Medical Genetics Part A, 146A(2), 191–196.

Vorst, H. C. M., & Bermond, B. (2001). Validity and reliability of the Bermond-Vorst alexithymia questionnaire. Personality and Individual Differences, 30(3), 413–434.

Walsh, K. S., Velez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., et al. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 55(2), 131–138.

Wingbermühle, E., Egger, J., van der Burgt, I., & Verhoeven, W. (2009). Neuropsychological and behavioral aspects of Noonan syndrome. Hormone Research in Pædiatrics, 72(2), 15–23.

Wingbermühle, E., Egger, J. I., Verhoeven, W. M., van der Burgt, I., & Kessels, R. P. (2012). Affective functioning and social cognition in Noonan syndrome. Psychological Medicine, 42(2), 419–426.PubMed

Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplege, A. (2001). Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Archives of Dermatology, 137(11), 1421–1425.PubMed

Wolters, P., Burns, K., Martin, S., Baldwin, A., Dombi, E., Toledo-Tamula, M. A., et al. (2015). Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life. American Journal of Medical Genetics Part A, 167A(9), 2103–2113.PubMed

Wood, A., Massarano, A., Super, M., & Harrington, R. (1995). Behavioural aspects and psychiatric findings in Noonan’s syndrome. Archives of Disease in Childhood, 72, 153–155.PubMedPubMedCentral

Woodward, L. J., & Fergusson, D. M. (2001). Life course outcomes of young people with anxiety disorders in adolescence. Journal of the American Academy of Child & Adolescent Psychiatry, 40(9), 1086–1093.

Titel: A Review of Psychological, Social, and Behavioral Functions in the RASopathies
verfasst von: Karin S. Walsh
A. del Castillo
T. Kennedy
A. I. Karim
C. Semerjian
Publikationsdatum: 01.09.2020
Verlag: Springer International Publishing
Erschienen in: Journal of Pediatric Neuropsychology / Ausgabe 3/2020
Print ISSN: 2199-2681
Elektronische ISSN: 2199-2673
DOI: https://doi.org/10.1007/s40817-020-00088-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims

Methods

Results

Interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Relationship Between Task-Based and Parent Report-Based Measures of Attention and Executive Function in Children with Fetal Alcohol Spectrum Disorders (FASD)

Correlates of Sluggish Cognitive Tempo Among Clinic-Referred Youth: Expanding Awareness of Somatic Symptoms and Stress in the Clinical Picture

No Free, Appropriate, Public Education for Most Neuropsychologically Referred Outpatients